Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fenofibrate Adjuvant Therapy in Neonatal Exaggerated Hyperbilirubinemia
NCT06346743Phase 3Not yet recruiting
- Start
- Apr 2024
- Primary completion
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of fenofibrate in neonatal hyperbilirubinemia. Planned start Apr 2024; status: not yet recruiting.
02
Drugs
fenofibrate
03
Conditions
neonatal hyperbilirubinemia
Beyond the preview
Go deeper on NCT06346743.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06346743.